Skewed Research Essay

Companies manufacturing these drugs then work around this by lobbying their drugs as cures for Alzheimer, ADHD, ADD, dementia, dyslexia, and other cognitive defects.

The pharmaceutical industry along with the manufacturers of healthcare products and technologies often encourage the misappropriation and distribution of marginally beneficial products and technologies in the healthcare industry. These companies often use various advertising methods to influence members of the public to request their products and services without adequate knowledge of their effectiveness and implications to their medical condition.

An article was chosen from the University Library to evaluate the issue of unethical business research conduct. The article chose is called Flacking for Big Pharma: Drugmakers Don't Just Compromise Doctors; They Also Undermine the Top Medical Journals and Skew the Findings of Medical Research . The identification of the unethical business research involved in the article is given. The parties involved along with effected party is mentioned. The evaluation of the article also identifies how the unethical behavior affected the organization, injured party, and society. A proposition of

Drug companies claim most of their profits are reinvested to develop new drugs, yet the industry has refused to show government auditors its books (Clemente, 2004). In addition, pharmaceutical companies do not acknowledge the financial contribution of the government which funds research with the National Institutes of Health (NIH), the National Cancer Institute, and other public agencies. "The Federal Government, mainly through the NIH, funds about 36% of all U.S. medical research. . . Of the 21 most important drugs introduced between 1965 and 1992, 15 were developed using knowledge and techniques from federally funded research" (Barlett & Steele, 2004). Pfizer 's profits of $9.1 billion for 2002 were 28 percent, twice which of General Electric, nine times more than Wal-Mart and 31 times more than General Motors (Barlett & Steele, 2004). "Drugmakers ' net profit margins averaged 19 percent last year vs. 7.5 percent for all the companies in the S&P 500. The seven largest U.S. drugmakers made $31.2 billion last year" (Gibbs, 2003). This supports the findings of a recent online survey conducted by Weiss Ratings, Inc.: "forty-two percent of consumers polled blame pharmaceutical companies ' excessive profits for high prescription drug costs" ("Drug," 2004).

Many have accused that Food and Drug Administration is not aggressively monitoring drugs prices, the FDA is in charge of regulating devices and drug production. Big Pharma spends billions of dollars annually on direct-to- consumer advertising which entitles manipulative strategies (4). The theory behind such good progress is the company attracts doctors, scientist, and other health related personnel’s. Medical research teams and doctors conduct extensive research with funds from Big Pharma. Even though many accuse Big Pharma for not following their mission statement it has not restricted them from purchasing their prescriptions medications. Big Pharma a company with many tactics and strategies, have been hiring former government workers whom have authoritative links to gain political influence. Currently, they have hired, 36 who worked for a member of Congress, 13 who worked for a federal agency, 2 who worked for the White House (4). With influenced members from Congress, they use their connection to reach their company goals. Unfortunately, U.S law permits drug manufacture companies to set prescriptions drugs prices without any restriction from the FDA. On the other hand, other countries set a limit on what companies can charge bases on the benefit of the drug (4). There are many hidden facts, which Big Pharma does not reveal; for example, the company spends double the amount of advertising then they do on research. Persuasion is the key to pharmaceutical industry, paying physicians/surgeons to incorporate their names on research articles, with the intent of getting published in

In Marcia Angell’s book, The Truth About the Drug Companies: How They Deceive Us and What to do About It, she reveals to readers the truth about what the pharmaceutical drug companies do to make money and how it effects us as customers and patients. Angell shows through her use of facts from credible sources and her use of statistic and knowledge on the subject that the pharmaceutical industry has transformed into one that is more profit based than one that is trying to help out people with innovative medication.

Today, marketing research managers must fully take into account the marketing research process and marketing ethics while conducting their research. According to Brown (2014), the marketing research process is the process of gathering and interpreting data for use in developing, implementing, and monitoring the firm’s marketing plans; whereas marketing ethics are the principles, values, and standards of conduct followed by marketers. To stress the importance of both the marketing research process and ethics, I will apply the principles of each one to a different scenario.

Q: And are you aware that Dr. Zalaya testified that he thought Mr. Turner’s seizures would cease over the next year or two and that he could not say to a reasonable degree of medical certainty that Mr. Turner would need the Neurontin for the rest of his life?

“Neuroethics” is a recent term that increases the awareness of the neuroscience impact on human. Accordingly, these ethical issues have been addressed by ethical questions including whether or not the drugs that

Another issue is too much power is given to scientists in decision-making of candidate drugs. Also there were inadequacies and lack of communication between marketing and research. Merck’s marketing and research needed to realize that the making of the drug is not only the most important part in increasing sales, but it also included a strong advertising campaign that will satisfy the needs of the customers.

The Shifting of Balance: new settlers hard to adapt to indian ways, middle ground collapsed 19th century, Indians removed

However, with any trail and article, possible issues arise that must be questioned. For example, the article states that the trials ran for a 48 week period, which in my opinion was too short of a period to show the effectiveness of this drug. Drugs such as lamotrigine should be studied for several years in order to assess the long term effects of the drug on the brain, activity and overall effects on the patients bipolar condition. There could be a possibility that several long term effects could be produced in the long run but were unfortunately not done in trails to see these effects. Secondly, the article states that the trail was done as an open-trail. Open-trail’s unfortunately open the situation of bias as both the patients and the doctors have knowledge of the drug in use. The experiment should have involved the use of placebos so that the possibility of patient bias could be reduced and therefore making the overall trail much more successful. The possibility of bias can definitely make this trail untrustworthy and must definitely be seen with a grain of

For example, Vedula (2012) notes that FDA guidelines state pharmaceutical companies can use peer-reviewed articles to publicize evidence of a drug’s effectiveness for off-label uses, as long as a number of conditions are met—perhaps the most essential of which is that “the information disseminated must not be false or misleading.” However, Vedula continues, there is no unyielding regulation that all research findings have to be published. Therefore, a company can still choose to selectively disseminate favorable findings. His article concludes that there is now a copious amount of evidence that suggests selective reporting of study results, based on the strength and direction of findings, is performed extensively by the pharmaceutical industry.

Levelhedin is the new drug product of Rxcellent; a pharmaceutical company that needs to regain its revenues after two of their drugs came off patent. Levelhedin is a novel class of drugs that is meant to treat bipolar disorder patients. As a member of the marketing team, I am responsible for encouraging physicians to prescribe Levelhedin over the competitors by developing promotional literature. However, the ethical principles surrounding the side effects of the drug are up for questioning. Here, I discuss if and how Rxcellent violates any of the six ethical principles described in class.

Pharmaceutical companies should attempt to be as transparent as possible when marketing prescription drugs to the public. Their marketing efforts should not only convey the benefits of the prescription drug, but also easily convey the possible risks associated with the prescription drugs. Many patients may tend to think the benefits outweigh the potential risks of prescription drugs and may pressure their physician to prescribe it. Due to the way the prescription drug is marketed, the consumer may believe the